Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
Submitted by
admin
on May 23, 2022 - 10:17am
Source:
BioSpace
News Tags:
Alcon
M&A
Eysuvis
dry eye
Headline:
Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
snippet:
Expands ophthalmic eye drop portfolio leveraging market access expertise and newly created US ophthalmic eye drop sales force
EYSUVIS complements Systane Preservative-Free by expanding treatment options for dry eye
Do Not Allow Advertisers to Use My Personal information
